Ortho Biotech recalls Procrit batch
11 Aug 2008
Johnson & Johnson subsidiary Ortho Biotech has announced the voluntary recall of one manufacturing lot of its Procrit drug.
Post-manufacturing inspections revealed cracks in the necks of "a small number" of vials, the company said.
It stated that even slight cracks could affect the sterility of the medicine and any affected vials should not therefore be used for injections.
The firm said the affected batch is lot number P114942A, from which more than 44,000 vials were distributed between April 15th and July 17th this year.
It added that the product recall is being carried out in cooperation with the US Food and Drug Administration.
Meanwhile, Watson Pharmaceuticals has announced it is recalling a batch of its 75 mcg/hr Fentanyl Transdermal System patches sold in the US due to a fault.
The firm stated that a small number of patches in lot number 92461850 have been found to be leaking gel and while no injuries have been reported, exposure to the gel could could serious and even fatal reactions.
